Pharmacoeconomics :: principles and practice /
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Torino, Italy :
SEEd srl.,
2012.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | 1 online resource |
| Bibliographie: | Includes bibliographical references. |
| ISBN: | 9788897419389 8897419380 |
Internformat
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBU-ocn881727882 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 140625s2012 it ob 000 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d OCLCF |d EBLCP |d OCLCQ |d E7B |d MOZ |d YDXCP |d AGLDB |d MOR |d PIFAG |d ZCU |d MERUC |d OCLCQ |d U3W |d STF |d VTS |d NRAMU |d ICG |d VT2 |d AU@ |d OCLCQ |d TKN |d DKC |d OCLCQ |d AJS |d OCLCO |d OCLCQ |d QGK |d OCLCO |d OCLCL |d UEJ |d OCLCO |d OCLCQ | ||
| 019 | |a 896846620 |a 903700160 |a 961566079 |a 962660730 |a 1259073371 | ||
| 020 | |a 9788897419389 |q (electronic bk.) | ||
| 020 | |a 8897419380 |q (electronic bk.) | ||
| 020 | |z 9788897419372 | ||
| 020 | |z 8897419372 | ||
| 035 | |a (OCoLC)881727882 |z (OCoLC)896846620 |z (OCoLC)903700160 |z (OCoLC)961566079 |z (OCoLC)962660730 |z (OCoLC)1259073371 | ||
| 050 | 4 | |a RS100 |b .P73 2012eb | |
| 072 | 7 | |a BUS |x 070000 |2 bisacsh | |
| 082 | 7 | |a 338.4/76151 |2 23 | |
| 049 | |a MAIN | ||
| 100 | 1 | |a Pradelli, Lorenzo, |e author. | |
| 245 | 1 | 0 | |a Pharmacoeconomics : |b principles and practice / |c Lorenzo Pradelli, Albert Wertheimer. |
| 264 | 1 | |a Torino, Italy : |b SEEd srl., |c 2012. | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 504 | |a Includes bibliographical references. | ||
| 588 | 0 | |a Online resource; title from pdf information screen (Ebsco, viewed June 25, 2014). | |
| 505 | 0 | |a Title Page; Colophon ; Table of Contents; Preface; Introduction; Health Care Dilemma; Opportunity Cost; Efficiency and Equity; Pharmacoeconomics; Sensitivity Analysis; Summary; Further Readings; 1 Definitions and Basic Concepts; 1.1 Definitions; 1.2 Costs; 1.3 Consequences; 1.4 Perspectives; 1.5 Time Horizon; 2 Pharmacoeconomic Evaluations; 2.1 Introduction; 2.2 Cost Analysis; 2.3 Cost-outcomes Analysis; 2.4 Utility; 2.5 Psychometrics; 3 Modeling Frameworks; 3.1 Steps in Decision Analysis; 3.2 Influence Diagrams; 3.3 Markov Models; 3.4 Discrete-event Simulation; 3.5 Agent-based Models. | |
| 505 | 8 | |a 4 Budget Impact Analysis4.1 Introduction; 4.2 Example: Budget Impact Analysis of Clinical Guidelines in COPD Patients; 5 Patient Reported Outcomes; 5.1 Introduction; 5.2 From Biological Measures to Patient Reported Outcome; 5.3 Quality of Life, Health Related Quality of Life, and Patient Reported Outcomes; 5.4 PRO Dimensions; 5.5 Every Patient has Individual Health Perceptions; 5.6 Applications of PRO Instruments; 5.7 Identifying an Appropriate Instrument for Measuring PRO; 5.8 PRO Instruments; 5.9 When are the Results of PROs Relevant?; 5.10 Summary and Conclusion. | |
| 505 | 8 | |a 6 Data Sources and Accounting for Uncertainty6.1 Data Sources; 6.2 Statistical Analysis; 6.3 Accounting for Uncertainty; 6.4 Pharmacoeconomic Studies; 6.5 Conclusions: Evaluating Pharmacoeconomic Studies; References; Glossary; Authors. | |
| 546 | |a English. | ||
| 650 | 0 | |a Drugs |x Cost effectiveness. | |
| 650 | 0 | |a Pharmacy |x Economic aspects. | |
| 650 | 0 | |a Decision making. |0 http://id.loc.gov/authorities/subjects/sh85036199 | |
| 650 | 2 | |a Decision Making |0 https://id.nlm.nih.gov/mesh/D003657 | |
| 650 | 6 | |a Médicaments |x Coût-efficacité. | |
| 650 | 6 | |a Prise de décision. | |
| 650 | 7 | |a decision making. |2 aat | |
| 650 | 7 | |a BUSINESS & ECONOMICS |x Industries |x General. |2 bisacsh | |
| 650 | 7 | |a Decision making |2 fast | |
| 650 | 7 | |a Drugs |x Cost effectiveness |2 fast | |
| 650 | 7 | |a Pharmacy |x Economic aspects |2 fast | |
| 700 | 1 | |a Wertheimer, Albert I., |e author. |1 https://id.oclc.org/worldcat/entity/E39PCjHYhF43yjfphbVxHJDm8d |0 http://id.loc.gov/authorities/names/n80118348 | |
| 758 | |i has work: |a Pharmacoeconomics (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFt43tvcxK4JCXtx7vQQbd |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |a Pradelli, Lorenzo. |t Pharmacoeconomics. |b First edition. |z 9788897419372 |z 8897419372 |w (OCoLC)856054836 |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBU |q FWS_PDA_EBU |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=783514 |3 Volltext |
| 938 | |a EBL - Ebook Library |b EBLB |n EBL3034683 | ||
| 938 | |a ebrary |b EBRY |n ebr10960569 | ||
| 938 | |a EBSCOhost |b EBSC |n 783514 | ||
| 938 | |a YBP Library Services |b YANK |n 11830318 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBU | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBU-ocn881727882 |
|---|---|
| _version_ | 1816796913973854208 |
| adam_text | |
| any_adam_object | |
| author | Pradelli, Lorenzo Wertheimer, Albert I. |
| author_GND | http://id.loc.gov/authorities/names/n80118348 |
| author_facet | Pradelli, Lorenzo Wertheimer, Albert I. |
| author_role | aut aut |
| author_sort | Pradelli, Lorenzo |
| author_variant | l p lp a i w ai aiw |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RS100 |
| callnumber-raw | RS100 .P73 2012eb |
| callnumber-search | RS100 .P73 2012eb |
| callnumber-sort | RS 3100 P73 42012EB |
| callnumber-subject | RS - Pharmacy |
| collection | ZDB-4-EBU |
| contents | Title Page; Colophon ; Table of Contents; Preface; Introduction; Health Care Dilemma; Opportunity Cost; Efficiency and Equity; Pharmacoeconomics; Sensitivity Analysis; Summary; Further Readings; 1 Definitions and Basic Concepts; 1.1 Definitions; 1.2 Costs; 1.3 Consequences; 1.4 Perspectives; 1.5 Time Horizon; 2 Pharmacoeconomic Evaluations; 2.1 Introduction; 2.2 Cost Analysis; 2.3 Cost-outcomes Analysis; 2.4 Utility; 2.5 Psychometrics; 3 Modeling Frameworks; 3.1 Steps in Decision Analysis; 3.2 Influence Diagrams; 3.3 Markov Models; 3.4 Discrete-event Simulation; 3.5 Agent-based Models. 4 Budget Impact Analysis4.1 Introduction; 4.2 Example: Budget Impact Analysis of Clinical Guidelines in COPD Patients; 5 Patient Reported Outcomes; 5.1 Introduction; 5.2 From Biological Measures to Patient Reported Outcome; 5.3 Quality of Life, Health Related Quality of Life, and Patient Reported Outcomes; 5.4 PRO Dimensions; 5.5 Every Patient has Individual Health Perceptions; 5.6 Applications of PRO Instruments; 5.7 Identifying an Appropriate Instrument for Measuring PRO; 5.8 PRO Instruments; 5.9 When are the Results of PROs Relevant?; 5.10 Summary and Conclusion. 6 Data Sources and Accounting for Uncertainty6.1 Data Sources; 6.2 Statistical Analysis; 6.3 Accounting for Uncertainty; 6.4 Pharmacoeconomic Studies; 6.5 Conclusions: Evaluating Pharmacoeconomic Studies; References; Glossary; Authors. |
| ctrlnum | (OCoLC)881727882 |
| dewey-full | 338.4/76151 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/76151 |
| dewey-search | 338.4/76151 |
| dewey-sort | 3338.4 576151 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04229cam a2200625 i 4500</leader><controlfield tag="001">ZDB-4-EBU-ocn881727882</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">140625s2012 it ob 000 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">OCLCF</subfield><subfield code="d">EBLCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">E7B</subfield><subfield code="d">MOZ</subfield><subfield code="d">YDXCP</subfield><subfield code="d">AGLDB</subfield><subfield code="d">MOR</subfield><subfield code="d">PIFAG</subfield><subfield code="d">ZCU</subfield><subfield code="d">MERUC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">U3W</subfield><subfield code="d">STF</subfield><subfield code="d">VTS</subfield><subfield code="d">NRAMU</subfield><subfield code="d">ICG</subfield><subfield code="d">VT2</subfield><subfield code="d">AU@</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">TKN</subfield><subfield code="d">DKC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">AJS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">QGK</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">UEJ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">896846620</subfield><subfield code="a">903700160</subfield><subfield code="a">961566079</subfield><subfield code="a">962660730</subfield><subfield code="a">1259073371</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9788897419389</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">8897419380</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9788897419372</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">8897419372</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)881727882</subfield><subfield code="z">(OCoLC)896846620</subfield><subfield code="z">(OCoLC)903700160</subfield><subfield code="z">(OCoLC)961566079</subfield><subfield code="z">(OCoLC)962660730</subfield><subfield code="z">(OCoLC)1259073371</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RS100</subfield><subfield code="b">.P73 2012eb</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">BUS</subfield><subfield code="x">070000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">338.4/76151</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Pradelli, Lorenzo,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmacoeconomics :</subfield><subfield code="b">principles and practice /</subfield><subfield code="c">Lorenzo Pradelli, Albert Wertheimer.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Torino, Italy :</subfield><subfield code="b">SEEd srl.,</subfield><subfield code="c">2012.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Online resource; title from pdf information screen (Ebsco, viewed June 25, 2014).</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Title Page; Colophon ; Table of Contents; Preface; Introduction; Health Care Dilemma; Opportunity Cost; Efficiency and Equity; Pharmacoeconomics; Sensitivity Analysis; Summary; Further Readings; 1 Definitions and Basic Concepts; 1.1 Definitions; 1.2 Costs; 1.3 Consequences; 1.4 Perspectives; 1.5 Time Horizon; 2 Pharmacoeconomic Evaluations; 2.1 Introduction; 2.2 Cost Analysis; 2.3 Cost-outcomes Analysis; 2.4 Utility; 2.5 Psychometrics; 3 Modeling Frameworks; 3.1 Steps in Decision Analysis; 3.2 Influence Diagrams; 3.3 Markov Models; 3.4 Discrete-event Simulation; 3.5 Agent-based Models.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">4 Budget Impact Analysis4.1 Introduction; 4.2 Example: Budget Impact Analysis of Clinical Guidelines in COPD Patients; 5 Patient Reported Outcomes; 5.1 Introduction; 5.2 From Biological Measures to Patient Reported Outcome; 5.3 Quality of Life, Health Related Quality of Life, and Patient Reported Outcomes; 5.4 PRO Dimensions; 5.5 Every Patient has Individual Health Perceptions; 5.6 Applications of PRO Instruments; 5.7 Identifying an Appropriate Instrument for Measuring PRO; 5.8 PRO Instruments; 5.9 When are the Results of PROs Relevant?; 5.10 Summary and Conclusion.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">6 Data Sources and Accounting for Uncertainty6.1 Data Sources; 6.2 Statistical Analysis; 6.3 Accounting for Uncertainty; 6.4 Pharmacoeconomic Studies; 6.5 Conclusions: Evaluating Pharmacoeconomic Studies; References; Glossary; Authors.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Cost effectiveness.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmacy</subfield><subfield code="x">Economic aspects.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Decision making.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85036199</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Decision Making</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D003657</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médicaments</subfield><subfield code="x">Coût-efficacité.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Prise de décision.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">decision making.</subfield><subfield code="2">aat</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BUSINESS & ECONOMICS</subfield><subfield code="x">Industries</subfield><subfield code="x">General.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Decision making</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs</subfield><subfield code="x">Cost effectiveness</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmacy</subfield><subfield code="x">Economic aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wertheimer, Albert I.,</subfield><subfield code="e">author.</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCjHYhF43yjfphbVxHJDm8d</subfield><subfield code="0">http://id.loc.gov/authorities/names/n80118348</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Pharmacoeconomics (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCFt43tvcxK4JCXtx7vQQbd</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Pradelli, Lorenzo.</subfield><subfield code="t">Pharmacoeconomics.</subfield><subfield code="b">First edition.</subfield><subfield code="z">9788897419372</subfield><subfield code="z">8897419372</subfield><subfield code="w">(OCoLC)856054836</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBU</subfield><subfield code="q">FWS_PDA_EBU</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=783514</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBL - Ebook Library</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL3034683</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10960569</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">783514</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">11830318</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBU</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBU-ocn881727882 |
| illustrated | Not Illustrated |
| indexdate | 2024-11-26T14:49:14Z |
| institution | BVB |
| isbn | 9788897419389 8897419380 |
| language | English |
| oclc_num | 881727882 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource |
| psigel | ZDB-4-EBU |
| publishDate | 2012 |
| publishDateSearch | 2012 |
| publishDateSort | 2012 |
| publisher | SEEd srl., |
| record_format | marc |
| spelling | Pradelli, Lorenzo, author. Pharmacoeconomics : principles and practice / Lorenzo Pradelli, Albert Wertheimer. Torino, Italy : SEEd srl., 2012. 1 online resource text txt rdacontent computer c rdamedia online resource cr rdacarrier Includes bibliographical references. Online resource; title from pdf information screen (Ebsco, viewed June 25, 2014). Title Page; Colophon ; Table of Contents; Preface; Introduction; Health Care Dilemma; Opportunity Cost; Efficiency and Equity; Pharmacoeconomics; Sensitivity Analysis; Summary; Further Readings; 1 Definitions and Basic Concepts; 1.1 Definitions; 1.2 Costs; 1.3 Consequences; 1.4 Perspectives; 1.5 Time Horizon; 2 Pharmacoeconomic Evaluations; 2.1 Introduction; 2.2 Cost Analysis; 2.3 Cost-outcomes Analysis; 2.4 Utility; 2.5 Psychometrics; 3 Modeling Frameworks; 3.1 Steps in Decision Analysis; 3.2 Influence Diagrams; 3.3 Markov Models; 3.4 Discrete-event Simulation; 3.5 Agent-based Models. 4 Budget Impact Analysis4.1 Introduction; 4.2 Example: Budget Impact Analysis of Clinical Guidelines in COPD Patients; 5 Patient Reported Outcomes; 5.1 Introduction; 5.2 From Biological Measures to Patient Reported Outcome; 5.3 Quality of Life, Health Related Quality of Life, and Patient Reported Outcomes; 5.4 PRO Dimensions; 5.5 Every Patient has Individual Health Perceptions; 5.6 Applications of PRO Instruments; 5.7 Identifying an Appropriate Instrument for Measuring PRO; 5.8 PRO Instruments; 5.9 When are the Results of PROs Relevant?; 5.10 Summary and Conclusion. 6 Data Sources and Accounting for Uncertainty6.1 Data Sources; 6.2 Statistical Analysis; 6.3 Accounting for Uncertainty; 6.4 Pharmacoeconomic Studies; 6.5 Conclusions: Evaluating Pharmacoeconomic Studies; References; Glossary; Authors. English. Drugs Cost effectiveness. Pharmacy Economic aspects. Decision making. http://id.loc.gov/authorities/subjects/sh85036199 Decision Making https://id.nlm.nih.gov/mesh/D003657 Médicaments Coût-efficacité. Prise de décision. decision making. aat BUSINESS & ECONOMICS Industries General. bisacsh Decision making fast Drugs Cost effectiveness fast Pharmacy Economic aspects fast Wertheimer, Albert I., author. https://id.oclc.org/worldcat/entity/E39PCjHYhF43yjfphbVxHJDm8d http://id.loc.gov/authorities/names/n80118348 has work: Pharmacoeconomics (Text) https://id.oclc.org/worldcat/entity/E39PCFt43tvcxK4JCXtx7vQQbd https://id.oclc.org/worldcat/ontology/hasWork Print version: Pradelli, Lorenzo. Pharmacoeconomics. First edition. 9788897419372 8897419372 (OCoLC)856054836 FWS01 ZDB-4-EBU FWS_PDA_EBU https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=783514 Volltext |
| spellingShingle | Pradelli, Lorenzo Wertheimer, Albert I. Pharmacoeconomics : principles and practice / Title Page; Colophon ; Table of Contents; Preface; Introduction; Health Care Dilemma; Opportunity Cost; Efficiency and Equity; Pharmacoeconomics; Sensitivity Analysis; Summary; Further Readings; 1 Definitions and Basic Concepts; 1.1 Definitions; 1.2 Costs; 1.3 Consequences; 1.4 Perspectives; 1.5 Time Horizon; 2 Pharmacoeconomic Evaluations; 2.1 Introduction; 2.2 Cost Analysis; 2.3 Cost-outcomes Analysis; 2.4 Utility; 2.5 Psychometrics; 3 Modeling Frameworks; 3.1 Steps in Decision Analysis; 3.2 Influence Diagrams; 3.3 Markov Models; 3.4 Discrete-event Simulation; 3.5 Agent-based Models. 4 Budget Impact Analysis4.1 Introduction; 4.2 Example: Budget Impact Analysis of Clinical Guidelines in COPD Patients; 5 Patient Reported Outcomes; 5.1 Introduction; 5.2 From Biological Measures to Patient Reported Outcome; 5.3 Quality of Life, Health Related Quality of Life, and Patient Reported Outcomes; 5.4 PRO Dimensions; 5.5 Every Patient has Individual Health Perceptions; 5.6 Applications of PRO Instruments; 5.7 Identifying an Appropriate Instrument for Measuring PRO; 5.8 PRO Instruments; 5.9 When are the Results of PROs Relevant?; 5.10 Summary and Conclusion. 6 Data Sources and Accounting for Uncertainty6.1 Data Sources; 6.2 Statistical Analysis; 6.3 Accounting for Uncertainty; 6.4 Pharmacoeconomic Studies; 6.5 Conclusions: Evaluating Pharmacoeconomic Studies; References; Glossary; Authors. Drugs Cost effectiveness. Pharmacy Economic aspects. Decision making. http://id.loc.gov/authorities/subjects/sh85036199 Decision Making https://id.nlm.nih.gov/mesh/D003657 Médicaments Coût-efficacité. Prise de décision. decision making. aat BUSINESS & ECONOMICS Industries General. bisacsh Decision making fast Drugs Cost effectiveness fast Pharmacy Economic aspects fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85036199 https://id.nlm.nih.gov/mesh/D003657 |
| title | Pharmacoeconomics : principles and practice / |
| title_auth | Pharmacoeconomics : principles and practice / |
| title_exact_search | Pharmacoeconomics : principles and practice / |
| title_full | Pharmacoeconomics : principles and practice / Lorenzo Pradelli, Albert Wertheimer. |
| title_fullStr | Pharmacoeconomics : principles and practice / Lorenzo Pradelli, Albert Wertheimer. |
| title_full_unstemmed | Pharmacoeconomics : principles and practice / Lorenzo Pradelli, Albert Wertheimer. |
| title_short | Pharmacoeconomics : |
| title_sort | pharmacoeconomics principles and practice |
| title_sub | principles and practice / |
| topic | Drugs Cost effectiveness. Pharmacy Economic aspects. Decision making. http://id.loc.gov/authorities/subjects/sh85036199 Decision Making https://id.nlm.nih.gov/mesh/D003657 Médicaments Coût-efficacité. Prise de décision. decision making. aat BUSINESS & ECONOMICS Industries General. bisacsh Decision making fast Drugs Cost effectiveness fast Pharmacy Economic aspects fast |
| topic_facet | Drugs Cost effectiveness. Pharmacy Economic aspects. Decision making. Decision Making Médicaments Coût-efficacité. Prise de décision. decision making. BUSINESS & ECONOMICS Industries General. Decision making Drugs Cost effectiveness Pharmacy Economic aspects |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=783514 |
| work_keys_str_mv | AT pradellilorenzo pharmacoeconomicsprinciplesandpractice AT wertheimeralberti pharmacoeconomicsprinciplesandpractice |